Open access

Introductory Chapter: Optimizing the Management Outcomes in Patients with Temporomandibular Disorder

Written By

Buket Aybar, Yusuf Emes and Guhan Dergin

Published: 28 February 2018

DOI: 10.5772/intechopen.73537

From the Edited Volume

Temporomandibular Joint Pathology - Current Approaches and Understanding

Edited by Yusuf Emes, Buket Aybar and Gühan Dergin

Chapter metrics overview

1,125 Chapter Downloads

View Full Metrics

1. Introduction

Being one of the most controversial topics in dentistry, treatment of temporomandibular disorders (TMDs) requires the clinician to determine the patients’ needs and try to help the patient based on the most recent scientific evidence. TMDs are today commonly considered as a collection of various conditions of the temporomandibular joint (TMJ) or the masticatory muscles, which have different etiologies and mechanisms but presenting with similar symptoms [1]. Temporomandibular joint (TMJ) is affected by musculoskeletal disorders of the neck and masticatory system [2], and it is important for the clinical practitioner to tell the difference between the complaint originating from a musculoskeletal disorder and a complaint caused by an intra-articular disorder. By making this discernment, the patient can receive the optimal management and is protected from going under unnecessary surgical interventions.

There are several classification systems for the TMDs. The most recent and the most commonly used classification is the research diagnostic criteria for temporomandibular disorders (RDC-TMD) [3]. The most common intra-articular disorders are known to be reducing and nonreducing anterior disc displacements.

Anterior disc displacement is a condition in which the disc is positioned anteriorly to the mandibular condyle. If the disc reduces on opening, this is called anterior disc displacement with reduction. If the disc does not reduce on opening, then this is called anterior disc displacement without reduction (irreductible disc displacement) which is closely related to acute closed lock [1, 4].

Anteriorly displaced discs are common findings in the asymptomatic patients too. Studies by Larheim et al. [5] and Davant et al. [6] reported that magnetic resonance imaging (MRI) shows that about one third of the asymptomatic patients have displaced discs. It is also known that anteriorly displaced discs are most of the time displaced medially too [7], and it is important to evaluate the patient’s complaints and try to resolve the symptoms which are joint sounds, pain, and limited mouth opening. Chronic disc displacement can lead to the adhesion of the disc to the articular fossa. Pain in the TMJ is present in the 10% of the adult population and found more often in women [8]. However, it must be kept in mind that prior to initiating the treatment of a TMD patient, any possibilities of benign and malign tumors, developmental disorders, and fractures should be out-ruled.

If the overloading of the TMJ continues (parafunctional habits, bruxism) remodeling, mechanism is triggered. When overloading exceeds the limits of remodeling, degenerative process of the articular surfaces may begin leading to the osteoarthritis of the TMJ [9].

General consensus in treatment is that the most conservative and the most reversible method should be the initial treatment of choice. This is because temporomandibular disorders have a tendency of improving over time, and clinical experience shows that sometimes conservative treatments are as effective as invasive methods in relieving the patient’s symptoms [10].

When a patient is referred to a dentist for a complaint of temporomandibular disorder, oral history must be taken, and the patient should initially be examined for medical pathologies of the head and neck, including intraoral examination to search for a pain of dentoalveolar origin, type of occlusion, and any indicator of parafunctional habits such as bruxism. Imaging studies should be performed if necessary. The patients should also be evaluated for neurological and psychological conditions and should be referred to a specialist if necessary [11].

Management of the TMD patient may require a multidisciplinary approach. Physical therapy, cognitive behavioral intervention, educating the patients on self-care, and sometimes referring the patient to a psychologist or psychiatrist are all parts of the management. However, in most of the cases, a dental practitioner can begin the initial management. Using a step-by-step approach, a wide range of treatment modalities may be applied alone or in combination with each other. When conservative methods are ineffective in treating the patient, more invasive methods are applied, and open surgery may be indicated in patients not responding to other treatments. The practitioner should know that duration of symptoms is an important factor in the treatment success even in open surgery; earlier interventions have a higher chance for success [12].

Being an important aspect of the management of the patients with TMD, patient education requires full compliance of the patient because the treatment may fail due to the non-cooperative behavior of the patient.

The patient should be informed not to contact the teeth during rest (preventing clenching at daytime), being aware of parafunctional habits such as nail biting, lip-cheek chewing, and jaw protrusion [1].

The patient must be informed that he/she should have a soft diet and should limit the range of mouth opening. Slow chewing, decreasing the amount of daily tea, and coffee consumption are all parts of the treatment [1, 13]. Biting the food using incisors should be avoided, and biting on the effected side is recommended in case of joint pain [1].

Self-management is another important part of the management process. Self-massage is the initial self-management therapy, which is found to be very helpful in pain management especially in patients with masticatory muscle-originated pain [14, 15]. In myofascial pain massaging, the trigger points especially lead to improvement in pain even though it is temporary, and the massage must be continued to keep the benefits obtained from it [13].

Another self-management method is the application of moist heat or application of ice especially in cases of local myalgia and myofascial pain [1]. As a simple method, 20 minutes of hot bath is found to be effective in decreasing muscle pain.

Another method that can be used is the application of a hot pack to the tender site for 20 minutes three times a day. Heat relaxes the muscles and provides increased blood flow to the muscles. Also when cold is applied, as a reaction in order to increase the heat in the cold-applied muscle, the brain increases the blood flow to the muscle by vasodilatation providing an improvement in pain. Most of the studies on cold application are about acute pain, so there is little data on the application of cold for the management of chronic pain [16].

Pharmacological therapy is a part of TMD management. Nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, muscle relaxants, anxiolytic drugs, local anesthetics, antidepressants, and corticosteroids are indicated in TMD treatment.


2. Nonsteroidal anti-inflammatory drugs

Analgesics and NSAIDs form an important part of the pharmacological treatment of the osteoarthritic TMJ. The American College of Rheumatology guidelines recommend the use of paracetamol as the first medication of choice for the osteoarthritic hip and knee [17, 18, 19]. The use of paracetamol is also recommended for the management of osteoarthritis by some authors; however, they conclude that paracetamol is effective in osteoarthritis only at very high, near toxicity level doses. Ibuprofen and naproxen are recommended agents in osteoarthritis of the TMJ, but in the management of chronic pain, cox-2 inhibitors such as celecoxib or meloxicam should be preferred, not only for their effectiveness in chronic pain but also for less gastrointestinal effects, for they may require a prolonged use in chronic pain [20].

NSAIDs provide anti-inflammatory effects and analgesia for the TMD patients with osteoarthritis, capsulitis, synovitis, myositis, and pain related to reducing and nonreducing disc displacements [21].

Naproxen, ibuprofen, and diclofenac are the most often used NSAIDs [22]. Mejersjo and Wenneberg [23] have studied the effects of diclofenac 50 mg, given orally 3 ×1 in patients with TMJ arthritis. Their findings at the end of 3 months produced results similar to efficacy of occlusal appliances.

Anti-inflammatory properties of corticosteroids are greater than that of NSAIDs. Because the long term systemic use of corticosteroids may lead to complications such as Cushing’s syndrome, diabetes, and osteoporosis, they must be used only for a short time [24]. Anxiolytics is also recommended for a limited period of use because of their potential for dependency. Their sedative and muscle relaxant properties help reduce the effects of masticatory parafunctional habits such as bruxism. They help patients cope with stress, which is an important etiologic factor of TMD, stress-induced muscular hyperactivity, and dysfunction [22, 25]. A recent animal study has shown that the benzodiazepines also have effects on the biochemical content of the TMJ [26].

Usually used in combination with NSAIDs, centrally acting muscle relaxants help relax the masticatory muscles, and the patients may also benefit from their sedative properties [22]. The aim of using the muscle relaxants in the TMD patient is not only to manage acute muscle pain but also to decrease muscle activity for a limited period [27, 28].

The mechanism via which the muscle relaxants help the TMD patients is not totally clear. The prescribed doses are not high enough when taken orally to relax masticatory muscles locally. So, it is believed that their sedative and stress-reducing effects are more effective in helping the TMD patient [27].

Chlorzoxazone, cyclobenzaprine, methocarbamol, and diazepam are the most commonly used centrally acting muscle relaxants. All of these drugs have sedating effects, so the patients should preferably take them at bedtime [29].

Tizanidine is a spasmolytic agent, and there is so far only one clinical trial studying its effectiveness in the TMDs. Alencar et al. [30] have reported that tizanidine and cyclobenzaprine have effects similar to placebo on myofascial pain patients.

Even though there is little scientific evidence to support the efficacy of opioid analgesics in TMDs, they are usually prescribed together with non-opioid analgesics, in the management of TMJ pain. However, they must be used with caution for their tendency to create dependence in the patients. Opioid analgesics should be used only for short periods such as 2–3 weeks [22].

Hydrocodone is an opioid analgesic used in combination with a non-opioid analgesic or a NSAID in order to manage moderate to severe pain [31]. However, hydrocodone is not very effective in chronic pain cases. Codeine, morphine, oxycodone, hydromorphone, and fentanyl are also among the opioid analgesics preferred in the management of pain. The use of opioid analgesics is considered safe in some forms of noncancer pain as long as patients are selected carefully, well monitored for adverse effects, and onset of dependence [32].

However, it is still a subject of debate, which kind of opioids to use in the management of TMJ pain. Opioids are classified as short-acting and long-acting opioids. Short-acting opioids have the advantage of rapid onset of pain relief; however, they have a higher risk of drug-related adverse effects [33]. Long-acting opioids also help improve pain, and there is less reported drug-related adverse effects in patients [34]. However, Argoff and Silvershein [35] have not found any differences between the two types of drugs for efficacy.

Currently, due to lack of enough randomized controlled clinical trials on the clinical efficiency of pharmacological agents on TMD-related pain, it must be kept in mind that the pharmacological treatment in TMD patients is mostly empirical [36, 37].

Occlusal splints are the most commonly used treatment modality in the management of TMDs. Occlusal splints help in relieving the muscle hyperactivity originating from bruxism. Occlusal appliances also provide relief from occlusal overload to the TMJ and inhibit strain [38].

Casares et al. have [39] measured the effects of occlusal splints on intra-articular pressure using a pressure transducer, and they have concluded that stabilization splints significantly reduced the intra-articular pressure in the upper joint compartment. They have also reported better joint function as an outcome of splint treatment.

Conti et al. [40] have reported that even though behavioral treatment improves symptoms in patients with myofascial pain in short term, occlusal splints may accelerate the process, helping the patients to get positive results earlier. Another study even has hinted that occlusal splints may be helping improve the psychological status of the TMD patients [41].

First described for the temporomandibular joint by Nitzan et al. [42], arthrocentesis is simply the irrigation of the superior TMJ compartment using two needles and is considered to be an efficient process with low morbidity rate [43]. When applied for the treatment of TMJ osteoarthritis, this process removes degradation products and inflammatory mediators from the joint [44, 45]. However, Laskin [44] has stated that intra-articular lavage may also remove the favorable agents such as hyaluronic acid from the intra-articular space too. TMJ arthrocentesis may inhibit pain and increase the range of mandibular motion [42, 46, 47].

Two needles are used for irrigation and outflow of the irrigation solution, which is in most cases ringers lactate solution [9]. The amount of ringer’s solution is a subject of debate and varies between 60 ml [48] and 200 ml [49] in the literature.

The current understanding in the management of TMDs positions arthrocentesis after the initial conservative treatment modalities. When the conservative treatment fails, then arthrocentesis is indicated. However, some studies have evaluated the outcomes of arthrocentesis as an initial treatment. Vos et al. [50] have studied 80 patients in which 40 patients had arthrocentesis as an initial treatment, and the other 40 received conservative treatment as control. They have reported a more rapid improvement in symptoms following arthrocentesis, whereas the conservative treatment group showed a more gradual improvement. Their study has also shown that both methods produced similar results at the end of 26 weeks. However, they have discussed that this might be partially due to conservative treatment being dependent on patient compliance, whereas arthrocentesis is not, which may affect the outcome of the study. Machon et al. [45] have reported arthrocentesis to be more effective when combined with splint therapy.

Arthrocentesis may be performed in combination with the injection of various agents such as sodium hyaluronate [51] and corticosteroids (It has been previously reported that corticosteroids have positive effects on pain and function when injected intra-articularly) [52, 53]. For this reason, corticosteroid injection alone or in combination with arthrocentesis is used for treatment of the internal derangements of the TMJ. However, the injection of corticosteroids into the TMJ is still controversial due to reported complications such as bone necrosis, destruction of the cartilage, and progression of the degenerative disease [54, 55, 56]. These complications are reported to be mostly due to multiple injections or high-dose injections, and single injections are considered to be safe [57].

Sodium chlorate injections are also commonly used in the TMDs [58, 59, 60, 61]. They are either used in single injections or multiple injections, and multiple arthrocenteses followed by multiple injections of sodium hyaluronate have been found to be beneficial in patients with internal derangement [62, 63].

However, Manfredini et al. [51] have stated that a single dose of sodium hyaluronate injection following single arthrocentesis produced benefits similar to multiple interventions.

Emes et al. [64] have compared the effects of arthrocentesis to tenoxicam injection alone and reported no differences between the groups. However, their groups consisted of patients who did not respond to a previous arthrocentesis.

Sipahi et al. [48] have injected morphine and tramadol following arthrocentesis into the TMJs of patients with TMJ pain and have concluded that injection of morphine has significantly increased pain relief for 6 months. They have had similar pain relief with tramadol too, but this relief period was shorter in tramadol when compared to morphine.

Arthroscopy of the TMJ is an invasive surgical technique, which is used for the diagnosis and treatment of internal derangements of the TMJ [9]. It also has a low risk of degenerative articular change in the long term, which makes it a safe procedure (has lower complications than open surgery and less invasive than open surgery) [65]. However, it is not beneficial in examining the lower joint compartment. When there is a degenerative process affecting the lower joint compartment, usually an open surgery is indicated. Arthroscopy and arthrocentesis have similar benefits in TMDs, but arthroscopy is the technique of choice in the diagnosis and management of rheumatoid disorders affecting the TMJ [66]. It can also be used for techniques other than simple lysis and lavage; for example, Murakami et al. [67] have reported that arthroscopic lateral release of the capsule and anterior discal release were more effective than arthrocentesis in increasing the range of mouth opening.

Several studies show that the majority of TMDs can be managed by nonsurgical methods. When these methods fail to help the patient with his/her symptoms, then invasive techniques, such as arthrocentesis and arthroscopy, or open joint surgery are indicated [68]. Open procedures are used in order to reposition the anteriorly displaced disc, remove the anteriorly displaced disc, or remove and replace it (by temporalis flap, auricular cartilage, or an alloplastic material) [69, 70]. Several studies conclude that, in the treatment of the internal derangement of TMJ, open surgery is more effective in decreasing pain when compared to arthroscopic surgery [69, 70, 71, 72, 73].


3. Conclusion

The treatment of the TMD patient is challenging for the clinician because of the complex pathophysiology of the disorder, and deciding the optimal method for these patients is a difficult task. Our current treatment modalities all have some degree of placebo properties, and due to lack of randomized controlled clinical trials with placebo, our treatment protocols may fall within the boundaries of empirical treatment. In most cases, optimal treatment is the treatment targeting the patient’s individual needs, a step-by-step approach, avoiding aggressive, radical surgical protocols as much as possible, will be beneficial for the patient and increase the successful outcomes of our treatment.


  1. 1. McNeill C, Rudd PA. Diagnosis and non-surgical management of orofacial pain. In: Andersson L, Kahnberg K, Pogrel MA, editors. Oral and Maxillofacial Surgery. West Sussex: Blackwell; 2010. pp. 1175-1197
  2. 2. Lipton JA, Ship JA, Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. Journal of the American Dental Association (1939). 1993;124(10):115-121
  3. 3. Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, et al. Diagnostic criteria for Temporomandibular disorders (DC/TMD) for clinical and research applications: Recommendations of the international RDC/TMD consortium network* and orofacial pain special interest group. Journal of Oral & Facial Pain and Headache. 2014 Winter;28(1):6-27
  4. 4. Sidebottom AJ. How do I manage restricted mouth opening secondary to problems with the temporomandibular joint? The British Journal of Oral & Maxillofacial Surgery. 2013 Sep;51(6):469-472
  5. 5. Larheim TA, Westesson PL, Sano T. Temporomandibular joint disk displacement: Comparison in asymptomatic volunteers and patients. Radiology. 2001;218(2):428-432
  6. 6. Davant TSI, Greene CS, Perry HT, Lautenschlager EP. A quantitative computer-assisted analysis of the disc displacement in patients with internal derangement using sagittal view and magnetic resonance imaging. Journal of Oral and Maxillofacial Surgery. 1993;51(9):974-979
  7. 7. Kurita K, Westesson PL, Tasaki MM, Liedberg J. Temporomandibular joint: Diagnosis of medial and lateral disc displacement with anterioposterior arthrography. Correlations with cryosections. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 1992;73(3):364-368
  8. 8. LeResche L. Epidemiology of temporomandibular disorders: Implications for the investigation of etiologic factors. Critical Reviews in Oral Biology and Medicine. 1997;8(3):291-305
  9. 9. Holmlund A. Arthroscopy and arthroscopic surgery. In: Andersson L, Kahnberg K, Pogrel MA, editors. Oral and Maxillofacial Surgery. West Sussex: Blackwell; 2010. pp. 1197-1208
  10. 10. Greene CS. Management of patients with TMDs: A new standard of care. The International Journal of Prosthodontics. 2010;23(3):190-191
  11. 11. De Boever JA, Nilner M, Orthlieb JD, et al. Recommendations by the EACD for examination, diagnosis, and management of patients with temporomandibular disorders and orofacial pain by the general dental practitioner. Journal of Orofacial Pain. 2008;22(3):268-278
  12. 12. Al-Moraissi EA. Open versus arthroscopic surgery for the management of internal derangement of the temporomandibular joint: A meta-analysis of the literature. International Journal of Oral and Maxillofacial Surgery. 2015 Jun;44(6):763-770
  13. 13. Wright EF. Self-management Therapy. In: Manual of Temporomandibular Disorders. Iowa: Wiley-Blackwell; 2010. pp. 209-225
  14. 14. Riley JL 3rd, Myers CD, Currie TP, Mayoral O, Harris RG, Fisher JA, Gremillion HA, Robinson ME. Self -care behaviors associated with myofascial temporomandibular disorder pain. Journal of Orofacial Pain. 2007;21(3):194-202
  15. 15. DeBar LL, Vuckovic N, Schneider J, Ritenbaugh C. Use of complementary and alternative medicine for temporomandibular disorders. Journal of Orofacial Pain. 2003;17(3):224-236
  16. 16. Clark GT. Differential diagnosis and management of masticatory myogenous pain and dysfunction. In: Clark GT, Dione RA, editors. Orofacial Pain: A Guide to Medications and Management. West Sussex: Blackwell; 2012. pp. 271-294
  17. 17. Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, et al. Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. Arthritis and Rheumatism. 1995;38(11):1535-1540
  18. 18. Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, et al.; American College of Rheumatology. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. Arthritis and Rheumatism. 1995;38(11):1541-1546
  19. 19. Lane NE, Thompson JM. Management of osteoarthritis in the primary-care setting: An evidence-based approach to treatment. The American Journal of Medicine. 1997;103(6A):25S-30S
  20. 20. Teruel A, Broussard JS, Clark GT. Temporomandibular joint arthritis: Implications, diagnosis, and management. In: Clark GT, Dione RA, editors. Orofacial Pain: A Guide to Medications and Management. West Sussex: Blackwell; 2012. pp. 271-294
  21. 21. Syrop S. Pharmacologic management of myofascial pain and dysfunction. Oral and Maxillofacial Surgery Clinics of North America. 1995;7:87-97
  22. 22. Karlis V, Glickman R. Nonsurgical management of temporomandibular disorders. In: Miloro M, Ghali GE, Larsen PE, Waite PD, editors. Peterson’s Principles of Oral and Maxillofacial Surgery. Second ed. Vol. 2. Ontario, Canada: BC Decker; 2004. pp. 949-961
  23. 23. Mejersjo C, Wenneberg B. Diclofenac sodium and occlusal splint therapy in TMJ osteoarthritis: A randomized controlled trial. Journal of Oral Rehabilitation. 2008;35(10):729-738
  24. 24. Streeten DHP. Corticosteroid therapy, complication and therapeutic indication. JAMA. 1975;232(10):1046-1059
  25. 25. Scrivani SJ, Keith DA, Kaban LB. Temporomandibular disorders. The New England Journal of Medicine. 2008;359(25):2693-2705
  26. 26. Figueroba SR, Desjardins MP, Nani BD, et al. Effect of diazepam on temporomandibular joints in rats with increased occlusal vertical dimension. The British Journal of Oral & Maxillofacial Surgery. 2014;52(5):438-444
  27. 27. Dionne RA. Pharmacologic approaches. In: Laskin DM, Greene CS, Hylander WL, editors. Temporomandibular Disorders: An Evidence-Based Approach to Diagnosis and Treatment. Hanover Park, IL: Quintessence; 2006. pp. 347-357
  28. 28. Winocur E, Gavish A, Voikovitch M, Emodi -Perlman A, Eli I. Drugs and bruxism: A critical review. Journal of Orofacial Pain. 2003;17(2):99-111
  29. 29. Wright EF. Pharmacological management. In: Manual of Temporomandibular Disorders. Iowa: Wiley-Blackwell; 2010. pp. 251-264
  30. 30. Alencar FG Jr, Viana PG, Zamperini C, Becker A. Patient education and self-care for the management of jaw pain upon awakening: A randomized controlled clinical trial comparing the effectiveness of adding pharmacologic treatment with cyclobenzaprine or tizanidine. Journal of Oral & Facial Pain and Headache. 2014 Spring;28(2):119-127
  31. 31. Clark GT, Richeimer SH Opioids for chronic orofacial pain with a focus on nonmalignant chronic pain. In: Clark GT and Dione RA editors. Orofacial Pain: A Guide to Medications and Management. West Sussex: Blackwell; 66-83
  32. 32. Bouloux GF. Use of opioids in long-term management of temporomandibular joint dysfunction. Journal of Oral and Maxillofacial Surgery. 2011;69(7):1885-1891
  33. 33. Simon S. Opioids and treatment of chronic pain: Understanding pain patterns and the role for rapid-onset opioids. Med. Genetics in Medicine. 2005;7(4):54
  34. 34. McCarberg B, Barkin R. Long-acting opioids for chronic pain: Pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia. American Journal of Therapeutics. 2001;8(3):181
  35. 35. Argoff C, Silvershein D. A comparison of long-and short-acting opioids for the treatment of chronic noncancer pain: Tailoring therapy to meet patient needs. Mayo Clinic Proceedings. 2009;84(7):602-612
  36. 36. Cascos-Romero J, Va’zquez-Delgado E, Va’zquez-Rodrı’guez E, Gay-Escoda C. The use of tricyclic antidepressants in the treatment of temporomandibular joint disorders: systematic review of the literature of the last 20 years. Medicina Oral, Patología Oral y Cirugía Bucal. 2009;14(1):E3-E7
  37. 37. List T, Axelsson S, Leijon G. Pharmacologic interventions in the treatment of temporomandibular disorders, atypical facial pain, and burning mouth syndrome. A qualitative systematic review. Journal of Orofacial Pain. 2003;17(4):301-310
  38. 38. Kuttila M, Le Bell Y, Savolainen-Niemi E, Kuttila S, Alanen P. Efficiency of occlusal appliance therapy in secondary otalgia and temporomandibular disorders. Acta Odontologica Scandinavica. 2002;60(4):248-254
  39. 39. Casares G, Thomas A, Carmona J, Acero J, Vila CN. Influence of oral stabilization appliances in intra-articular pressure of the temporomandibular joint. Cranio. 2014;32(3):219-223
  40. 40. Conti PC, de Alencar EN, da Mota Corrêa AS, et al. Behavioural changes and occlusal splints are effective in the management of masticatory myofascial pain: A short-term evaluation. Journal of Oral Rehabilitation. 2012;39(10):754-760
  41. 41. Costa YM, Porporatti AL, Stuginski-Barbosa J, Bonjardim LR, Conti PC. Additional effect of occlusal splints on the improvement of psychological aspects in temporomandibular disorder subjects: A randomized controlled trial. Archives of Oral Biology. 2015;60(5):738-744
  42. 42. Nitzan DW, Dolwick MF, Martinez GA. Temporomandibular joint arthrocentesis: A simplified treatment for severe, limited mouth opening. Journal of Oral and Maxillofacial Surgery. 1991;49(11):1163-1167
  43. 43. Al-Belasy FA, Dolwick MF. Arthrocentesis for the treatment of temporomandibular joint closed lock: A review article. International Journal of Oral and Maxillofacial Surgery. 2007;36(9):773-782
  44. 44. Laskin DM. Arthrocentesis for the treatment of internal derangements of the temporomandibular joint. The Alpha Omegan. 2009;102(2):46-50
  45. 45. Machon V, Hirjak D, Lukas J: Therapy of the osteoarthritis of the temporomandibular joint. Journal of Cranio-Maxillo-Facial Surgery. 2011;39(2):127-130
  46. 46. Currie R. Temporomandibular joint arthrocentesis and lavage. Evidence-Based Dentistry. 2009;10(4):110
  47. 47. Monje-Gil F, Nitzan D, Gonzalez-Garcia R: Temporomandibular joint arthrocentesis. Review of the literature. Medicina Oral Patologia Oral y Cirugia Bucal. 2012;17(4): 575-581
  48. 48. Sipahi A, Satilmis T, Basa S. Comparative study in patients with symptomatic internal derangements of the temporomandibular joint: Analgesic outcomes of arthrocentesis with or without intra-articular morphine and tramadol. The British Journal of Oral & Maxillofacial Surgery. 2015;53(4):316-320
  49. 49. Sidebottom AJ. How do I manage restricted mouth opening secondary to problems with the temporomandibular joint? The British Journal of Oral & Maxillofacial Surgery. 2013;51(6):469-472
  50. 50. Vos LM, Huddleston Slater JJ, Stegenga B. Arthrocentesis as initial treatment for temporomandibular joint arthropathy: A randomized controlled trial. Journal of Cranio-Maxillo-Facial Surgery. 2014;42(5):134-139
  51. 51. Manfredini D, Rancitelli D, Ferronato G, et al. Arthrocentesis with or without additional drugs in temporomandibular joint inflammatory-degenerative disease: Comparison of six treatment protocols. Journal of Oral Rehabilitation. 2012;39(4):245-251
  52. 52. Hersh EV, Balasubramaniam R, Pinto A. Pharmacologic management of temporomandibular disorders. Oral and Maxillofacial Surgery Clinics of North America. 2008;20(2):197-210
  53. 53. Dimitroulis G, Dolwick MF. Temporomandibular disorders. Part3. Surgical treatment. Australian Dental Journal. 1996;41(3):16-20
  54. 54. Haddad IK. Temporomandibular joint osteoarthrosis. Histopathological study of the effects of intra-articular injection of triamcinolone acetonide. Saudi Medical Journal. 2000;21(7):675-679
  55. 55. Lida K, Kurita K, Tange K, Yoshida K. Necrosis of the articular tubercle after repeated injections of sodium hyaluronate in the temporomandibular joint. A case report. International Journal of Oral and Maxillofacial Surgery. 1998;27(4):278-279
  56. 56. Aggarwal S, Kumar A. A cortisone-wrecked and bony ankylosed temporomandibular joint. Plastic and Reconstructive Surgery. 1989;83(6):1084-1085
  57. 57. Toller PA. Use and misuse of intra-articular corticosteroids in treatment of temporomandibular joint pain. Proceedings of the Royal Society of Medicine. 1977;70(7):461-463
  58. 58. Mountziaris PM, Kramer PR, Mikos AG. Emerging intra-articular drug delivery systems for the temporomandibular joint. Methods. 2009;47(2):134-140
  59. 59. Bertolami CN, Gay T, Clark GT, Rendell SV, Liu C, et al. Use of sodium hyaluronate in treating temporomandibular joint disorders: A randomized, double-blind, placebo-controlled clinical trial. Journal of Oral and Maxillofacial Surgery. 1993;51(3):232-242
  60. 60. Hepguler S, Akkoc YS, Pehlivan M, Ozturk C, Celebi G, Saracoglu A, et al. The efficacy of intra-articular sodium hyaluronate in patients with reducing displaced disc of the temporomandibular joint. Journal of Oral Rehabilitation. 2002;29(1):80-86
  61. 61. Yeung RW, Chow RL, Samman N, Chiu K. Short-term therapeutic outcome of intraarticular high molecular weight hyaluronic acid injection for nonreducing disc displacement of the temporomandibular joint. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 2006;102(4):453-461
  62. 62. Guarda-Nardini L, Cadorin C, Frizziero A, Ferronato G, Manfredini D: Comparison of 2 hyaluronic acid drugs for the treatment of temporomandibular joint osteoarthritis. Journal of Oral and Maxillofacial Surgery. 2012;70(11):2522-2530
  63. 63. Tuncel U. Repeated sodium hyaluronate injections following multiple arthrocenteses in the treatment of early stage reducing disc displacement of the temporomandibular joint: A preliminary report. Journal of Cranio-Maxillo-Facial Surgery. 2012;40(8):685-689
  64. 64. Emes Y, Arpınar IŞ, Oncü B, et al. The next step in the treatment of persistent temporomandibular joint pain following arthrocentesis: A retrospective study of 18 cases. Journal of Cranio-Maxillo-Facial Surgery 2014;42(5):65-69
  65. 65. Israel HA. The use of arthroscopic surgery for treatment of temporomandibular joint disorders. Journal of Oral and Maxillofacial Surgery. 1999;57(5):579-582
  66. 66. Sidebottom AJ, Salha R. Management of the temporomandibular joint in rheumatoid disorders. The British Journal of Oral & Maxillofacial Surgery. 2013;51(3):191-198
  67. 67. Murakami K, Hosaka H, Moriya Y, Segami N, Iizuka T. Short-term treatment outcome study for the management of temporomandibular joint closed lock. A comparison of arthrocentesis to nonsurgical therapy and arthroscopic lysis and lavage. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 1995;80(3):253-257
  68. 68. Schiffman EL, Look JO, Hodges JS, Swift JQ, Decker KL, Hathaway KM, et al. Randomized effectiveness study of four therapeutic strategies for TMJ closed lock. Journal of Dental Research. 2007;86(1):58-63
  69. 69. Dolwick MF, Sanders B. TMJ Internal Derangement and Arthrosis: Surgical Atlas. St. Louis: Mosby; 1985
  70. 70. Witsenburg B, Freihofer HP. Replacement of the pathologic temporomandibular articular disc using autogenous cartilage of the external ear. International Journal of Oral Surgery. 1984;13(5):401-405
  71. 71. Politi M, Sembronio S, Robiony M, Costa F, Toro C, Undt G. High condylectomy and disc repositioning compared to arthroscopic lysis, lavage, and capsular stretch for the treatment of chronic closed lock of the temporomandibular joint. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 2007;103(1):27-33
  72. 72. Undt G, Murakami K, Rasse M, Ewers R. Open versus arthroscopic surgery for internal derangement of the temporomandibular joint: A retrospective study comparing two centres’ results using the jaw pain and function questionnaire. Journal of Cranio-Maxillo-Facial Surgery. 2006;34(4):234-241
  73. 73. Marciani RD, Ziegler RC. Temporomandibular joint surgery: A review of fifty-one operations. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 1983;56(5):472-476

Written By

Buket Aybar, Yusuf Emes and Guhan Dergin

Published: 28 February 2018